4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020671
Chief Scientific Officer sold 2,698 shares at an average $0.38 ($1,025)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loose Christopher R. Chief Scientific Officer | 2023-07-11 | Sale 10b5-1 | −1,363 | $0.37 | $504 | 201,022 | D: show line 1 in the form |
| Loose Christopher R. Chief Scientific Officer | 2023-07-12 | Sale 10b5-1 | −1,335 | $0.39 | $521 | 199,687 | D: show line 2 in the form |
| Open-market sales · 2,698 sh · avg $0.38 · $1,025 | |||||||
Loading xslF345X04/form4.xml…